ATXI Avenue Therapeutics, Inc.
Healthcare$0.23+0.00%OpenMarket Cap: $741,697
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.66
P/S
0.57
EV/EBITDA
0.79
DCF Value
$18.66
FCF Yield
-136.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
-149.3%
Net Margin
-124.8%
ROE
-65.8%
ROA
-71.0%
ROIC
-182.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-714.0K | $-695.0K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-955.0K | $-709.0K | $— | — |
| FY null | $1.4M | 100.0% | $-3.3M | $-2.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-724.0K | $-683.0K | $— | — |
| Q2 null | $1.4M | 100.0% | $297.0K | $335.0K | $— | — |
| Q1 null | $0.00 | NaN% | $-1.9M | $-1.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.6M | $-1.5M | $— | — |
| FY null | $0.00 | NaN% | $-11.3M | $-11.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.2M | $-3.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.8M | $-7.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.7M | $-4.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-2.1M | $640.0K | $0.03 | — |